Nektar Therapeutics - Company Profile
Powered by 
All the sales intelligence you need on Nektar Therapeutics in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Nektar Therapeutics fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Nektar Therapeutics.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Nektar Therapeutics (Nektar) is a clinical-stage biopharmaceutical company. Strong intellectual property portfolio, lead product candidate: rezpegaldesleukin, and focus on R&D activities are its strengths, even though declined financial performance is a cause for concern. The company could benefit from a strategic agreement, regulatory approvals and a positive outlook on the global pharmaceutical market. Nevertheless, its performance could be affected by government regulations, competitive environment in the industry, and increased pricing control.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer